Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13916556 | 1.00 | MAPK1 (0.48) | MAPK1DRD3 | |
| SCHEMBL9048142 | 0.92 | MAPK1 (0.38) | MAPK1DRD3 | |
| SCHEMBL3913743 | 0.79 | DRD3 (0.30) | DRD3 | |
| SCHEMBL13743617 | 0.79 | DRD3 (0.30) | DRD3 | |
| SCHEMBL14351155 | 0.75 | MAPK1 (0.56) | MAPK1 | |
| SCHEMBL15177748 | 0.68 | DRD3 (0.33) | DRD3 | |
| SCHEMBL17278812 | 0.68 | — | — | |
| Water SCHEMBL11498201 | 0.66 | MAPK1 (0.52) | MAPK1 | |
| SCHEMBL13908059 | 0.66 | MAPK1 (1.00) | MAPK1 | |
| SCHEMBL551145 | 0.66 | MAPK1 (1.00) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090076061-A1 | MUSCARINIC ACETYCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2009-03-19 | — | — | US | disclosed |
| US-20070293531-A1 | Muscarinic Acetycholine Receptor Antagonists | GLAXO GROUP LIMITED (GB) | 2007-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076061-A1 | MUSCARINIC ACETYCHOLINE RECEPTOR ANTAGONISTS | CHRM3, CHRNA7, CHRNA2 | MAPK1 4435/4885DRD3 795/4885 |
| US-20070293531-A1 | Muscarinic Acetycholine Receptor Antagonists | CHRM3, CHRNA7, CHRNA2 | MAPK1 4435/4885DRD3 795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.